Cargando…
Serum sphingolipid profiling as a novel biomarker for metabolic syndrome characterization
BACKGROUND: Sphingolipids are components of cell membrane structure, but also circulate in serum and are essential mediators of many cellular functions. While ceramides have been proposed previously as a useful biomarker for cardiometabolic disease, the involvement of other sphingolipids is still co...
Autores principales: | Berkowitz, Loni, Salazar, Cristian, Ryff, Carol D., Coe, Christopher L., Rigotti, Attilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791223/ https://www.ncbi.nlm.nih.gov/pubmed/36578837 http://dx.doi.org/10.3389/fcvm.2022.1092331 |
Ejemplares similares
-
Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk
por: Berkowitz, Loni, et al.
Publicado: (2022) -
Association between serum sphingolipids and eudaimonic well-being in white U.S. adults
por: Berkowitz, Loni, et al.
Publicado: (2021) -
Sphingolipid metabolism and signaling in cardiovascular diseases
por: Borodzicz-Jażdżyk, Sonia, et al.
Publicado: (2022) -
Race and sex differences in HDL peroxide content among American adults with and without type 2 diabetes
por: Flaherty, Shelby M., et al.
Publicado: (2022) -
Circulating sphingolipids in heart failure
por: Kovilakath, Anna, et al.
Publicado: (2023)